SOD1 and metabolic syndrome: We have demonstrated that MetS+ patients had an impaired antioxidant defense system (Table 2), as evidenced by statistically significantly lower TAS and higher TOS levels, as well as low activity of superoxide dismutase (SOD) and catalase (CAT) when compared to the control group.